| Cat. No. |
Product Name |
Information |
| PC-61610 |
NS 2028
|
NS 2028 is a potent, specific soluble guanylate cyclase (sGC) inhibitor with IC50 of 30 and 200 nM for basal and NO-stimulated enzymes, respectively. |
| PC-61609 |
S-3448
|
S-3448 is a potent, specific soluble guanylate cyclase (sGC) activator with EC50 of 0.68 uM, preferentially activates the NO-insensitive heme-oxidized form of sGC. |
| PC-61608 |
Ataciguat sodium
|
Ataciguat (HMR-1766) is a potent, specific soluble guanylate cyclase (sGC) activator with EC50 of 0.51 uM, preferentially activates the NO-insensitive heme-oxidized form of sGC. |
| PC-61607 |
Ataciguat
|
Ataciguat (HMR-1766) is a potent, specific soluble guanylate cyclase (sGC) activator with EC50 of 0.51 uM, preferentially activates the NO-insensitive heme-oxidized form of sGC. |
| PC-61606 |
Etriciguat
|
Etriciguat is a novel potent, selective, orally available soluble guanylate cyclase (sGC) stimulator.. |
| PC-60643 |
BI 703704
|
A novel potent soluble guanylate cyclase (sGC) activator. |
| PC-70008 |
GSK-2181236A
|
A potent, selective soluble guanylate cyclase (sGC) stimulator that increases sGC activity (cGMP formation) with EC50s of 27 and 25 nM for rat and human sGC, respectively. |
| PC-45371 |
Linaclotide
|
A potent and selective GC-C agonist (Ki=1.23-1.64 nM) that elicits pharmacological effects locally in the gastrointestinal tract. |
